Atlantic Union Bankshares’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.71M Sell
112,666
-8,825
-7% -$231K 0.05% 258
2026
Q1
$3.41M Sell
121,491
-134
-0.1% -$3.57K 0.07% 231
2025
Q4
$3.03M Sell
121,625
-12,365
-9% -$312K 0.06% 246
2025
Q3
$3.41M Buy
133,990
+32,645
+32% +$806K 0.06% 238
2025
Q2
$2.46M Buy
101,345
+27,097
+36% +$632K 0.06% 242
2025
Q1
$1.88M Sell
74,248
-1,156
-2% -$30.2K 0.11% 144
2024
Q4
$2M Sell
75,404
-8,764
-10% -$238K 0.12% 145
2024
Q3
$2.44M Sell
84,168
-1,980
-2% -$57.8K 0.14% 135
2024
Q2
$2.41M Sell
86,148
-2,943
-3% -$81K 0.15% 131
2024
Q1
$2.47M Sell
89,091
-56,950
-39% -$1.58M 0.21% 103
2023
Q4
$4.2M Buy
146,041
+2,802
+2% +$84.7K 0.39% 66
2023
Q3
$4.75M Buy
143,239
+14,426
+11% +$510K 0.49% 57
2023
Q2
$4.72M Buy
128,813
+23,607
+22% +$919K 0.47% 60
2023
Q1
$4.29M Buy
105,206
+2,319
+2% +$100K 0.45% 72
2022
Q4
$5.27M Sell
102,887
-5,253
-5% -$252K 0.56% 56
2022
Q3
$4.73M Sell
108,140
-12,109
-10% -$588K 0.54% 57
2022
Q2
$6.3M Sell
120,249
-1,511
-1% -$77K 0.64% 49
2022
Q1
$6.3M Sell
121,760
-5,709
-4% -$296K 0.55% 56
2021
Q4
$7.53M Sell
127,469
-11,224
-8% -$556K 0.64% 51
2021
Q3
$5.96M Sell
138,693
-701
-0.5% -$31.1K 0.56% 54
2021
Q2
$5.46M Buy
139,394
+7,158
+5% +$278K 0.53% 57
2021
Q1
$4.79M Sell
132,236
-4,898
-4% -$174K 0.49% 62
2020
Q4
$5.05M Sell
137,134
-14,037
-9% -$515K 0.52% 58
2020
Q3
$5.26M Buy
151,171
+262
+0.2% +$9.19K 0.61% 51
2020
Q2
$4.68M Sell
150,909
-166,131
-52% -$5.64M 0.58% 50
2020
Q1
$9.82M Sell
317,040
-4,663
-1% -$159K 1.43% 14
2019
Q4
$12M Sell
321,703
-1,984
-0.6% -$70.7K 1.53% 15
2019
Q3
$11M Sell
323,687
-4,220
-1% -$153K 1.48% 16
2019
Q2
$13.5M Buy
327,907
+209,639
+177% +$8.32M 1.81% 12
2019
Q1
$4.77M Sell
118,268
-9,509
-7% -$381K 1.32% 23
2018
Q4
$5.29M Sell
127,777
-720
-0.6% -$29.9K 1.73% 18
2018
Q3
$5.37M Sell
128,497
-10,829
-8% -$417K 1.62% 20
2018
Q2
$4.8M Sell
139,326
-1,509
-1% -$51.6K 1.56% 24
2018
Q1
$4.74M Buy
140,835
+9,864
+8% +$339K 1.47% 22
2017
Q4
$4.5M Sell
130,971
-199
-0.2% -$6.79K 1.39% 32
2017
Q3
$4.44M Buy
131,170
+875
+0.7% +$28.1K 1.5% 27
2017
Q2
$4.15M Buy
130,295
+5,473
+4% +$173K 1.44% 31
2017
Q1
$4.05M Buy
124,822
+10,513
+9% +$331K 1.45% 29
2016
Q4
$3.52M Buy
114,309
+2,416
+2% +$73.8K 1.31% 32
2016
Q3
$3.6M Buy
111,893
+1,806
+2% +$60.4K 1.37% 28
2016
Q2
$3.68M Buy
110,087
+6,380
+6% +$204K 1.42% 24
2016
Q1
$2.92M Buy
103,707
+12,573
+14% +$359K 1.21% 32
2015
Q4
$2.79M Buy
91,134
+7,371
+9% +$232K 1.22% 31
2015
Q3
$2.5M Buy
83,763
+11,838
+16% +$380K 1.16% 32
2015
Q2
$2.29M Sell
71,925
-3,325
-4% -$108K 1.08% 37
2015
Q1
$2.48M Sell
75,250
-636
-0.8% -$20.2K 1.14% 30
2014
Q4
$2.24M Buy
75,886
+5,187
+7% +$149K 1% 46
2014
Q3
$1.98M Buy
70,699
+4,803
+7% +$135K 0.93% 46
2014
Q2
$1.85M Buy
65,896
+43,560
+195% +$1.24M 0.86% 49
2014
Q1
$634K Buy
+22,336
New +$666K 0.29% 84

Other funds holding PFE

Atlantic Union Bankshares's PFE Position: Q2 2026 in Review

Atlantic Union Bankshares reduced its Pfizer (PFE) stake by 7.3% in Q2 2026, selling an estimated $231K and leaving 112,666 shares worth $2.71M. The position accounts for 0.05% of the portfolio, ranked #258.

Atlantic Union Bankshares first reported a position in PFE in Q1 2014 and has held it in 50 quarters since. The position peaked at $13.5M in Q2 2019. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Atlantic Union Bankshares held 112,666 shares of Pfizer worth $2.71M as of Q2 2026.
  • Atlantic Union Bankshares sold 8,825 Pfizer shares in Q2 2026, an estimated $231K.
  • Pfizer made up 0.05% of Atlantic Union Bankshares's portfolio in Q2 2026, its #258 holding.
  • Atlantic Union Bankshares first reported a position in Pfizer in Q1 2014 and has held it in 50 quarters since.
  • Atlantic Union Bankshares's Pfizer position peaked at $13.5M in Q2 2019.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Atlantic Union Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.